4.6 Article

Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Biochemistry & Molecular Biology

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. Garcia-Beltran et al.

Summary: New variants of SARS-CoV-2 show high resistance to vaccine neutralization, with some able to escape vaccine responses with just a few mutations, highlighting the importance of developing broadly protective measures against variants.
Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Article Multidisciplinary Sciences

Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates

Gozde Sir Karakus et al.

Summary: The SARS-CoV-2 vaccines are crucial for reducing disease incidence and mortality. Vaccine models containing GM-CSF induced significant antibody production with neutralization capacity, and the presence of adjuvant was more important in T cell response.

SCIENTIFIC REPORTS (2021)

Article Immunology

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

Ahmed Kandeil et al.

Summary: This study developed a whole virus vaccine and confirmed its safety and immunogenicity in laboratory animals. Antibodies were detected in animals starting from week three post-vaccination, with an increase in neutralizing antibodies after booster dose. Challenge infection in hamsters showed lower morbidity and shedding in the vaccinated group.

VACCINES (2021)

Article Multidisciplinary Sciences

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model

Sreelekshmy Mohandas et al.

Summary: The study demonstrated that the BBV152A and BBV152B vaccine candidates induced quick and robust immune responses, providing protection to Syrian hamsters from lung pathology after SARS-CoV-2 infection.

ISCIENCE (2021)

Letter Medicine, General & Internal

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization

Guo-Lin Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Virology

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates

Yan-Feng Yao et al.

Summary: The study demonstrated that an inactivated vaccine induced SARS-CoV-2-specific neutralizing antibodies in animals, providing partial or full protection. The results suggest the potential effectiveness of the vaccine in combating virus infection, offering hope for future human clinical trials.

VIROLOGICA SINICA (2021)

Article Medicine, General & Internal

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

Kunsulu Zakarya et al.

Summary: The QazCovid-in (R) vaccine, developed in Kazakhstan, showed good safety and tolerability in phase 1 and 2 clinical trials, inducing significant immune response that lasts at least 6 months.

ECLINICALMEDICINE (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Editorial Material Virology

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

Hongzhou Lu et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Medicine, General & Internal

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Gregory A. Poland et al.

LANCET (2020)

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Review Cell Biology

Coronavirus vaccine development: from SARS and MERS to COVID-19

Yen-Der Li et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Review Biochemistry & Molecular Biology

A systematic review of SARS-CoV-2 vaccine candidates

Yetian Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Biochemistry & Molecular Biology

Zoonotic origins of human coronaviruses

Zi-Wei Ye et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Shuo Su et al.

TRENDS IN MICROBIOLOGY (2016)

Article Biotechnology & Applied Microbiology

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

Anurodh Shankar Agrawal et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Editorial Material Virology

Coronaviruses: emerging and re-emerging pathogens in humans and animals

Susanna K. P. Lau et al.

VIROLOGY JOURNAL (2015)

Article Virology

Effect of Formaldehyde Inactivation on Poliovirus

Thomas Wilton et al.

JOURNAL OF VIROLOGY (2014)

Review Immunology

Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges

Iris Delrue et al.

EXPERT REVIEW OF VACCINES (2012)

Article Virology

Animal models and vaccines for SARS-CoV infection

Anjeanette Roberts et al.

VIRUS RESEARCH (2008)

Review Microbiology

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

SR Weiss et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)

Review Immunology

Immunopathogenesis of coronavirus infections: Implications for SARS

S Perlman et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Article Biochemistry & Molecular Biology

Identification of formaldehyde-induced modifications in proteins - Reactions with model peptides

B Metz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)